Geneva, June 22 -- International Clinical Trials Registry received information related to the study (ACTRN12626000687392) titled 'AGIFUS: Focused ultrasound for agitation associated with Alzheimer's disease (AD)' on June 10.
Study Type: Interventional
Study Design:
Purpose: Treatment
Allocation: Randomised controlled trial
Masking: Blinded (masking used)
Assignment: Parallel
Type of endpoint: Efficacy
Primary Sponsor: The University of Queensland
Condition:
Alzheimer's disease
Alzheimer's disease with associated agitation
Alzheimer's disease
Alzheimer's disease with associated agitation
Neurological - Alzheimer's disease
Intervention:
The UltraThera device (second-generation) is a non-invasive neuromodulation system. It functions...